Clinical Trial Update: Trial To Evaluate RPh201 In Treatment Of Partial Thickness Burn [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating RPh201 for partial-thickness burns has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Partial-thickness Burn
• Second-degree Burn

Drugs mentioned

• RPh201

Snippet

Sponsor: Regenera Pharma Ltd | Conditions: Second Degree Burn Less Than 5%TBSA, Partial Thickness Burn | Phase 1, Phase 2 | Status: WITHDRAWN